Article Information
History
- October 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Florian Lipsmeier*,1,†,
- Kirsten I. Taylor*,1,
- Ronald B. Postuma2,
- Ekaterina Volkova-Volkmar1,
- Timothy Kilchenmann1,
- Brit Mollenhauer3,4,
- Atieh Bamdadian1,
- Werner L. Popp1,
- Wei-Yi Cheng1,
- Yan Ping Zhang1,
- Detlef Wolf1,
- Jens Schjodt-Eriksen1,
- Anne Boulay5,
- Hanno Svoboda1,
- Wagner Zago6,
- Gennaro Pagano1 and
- Michael Lindemann1
- 1Roche Pharma Research and Early Development, pRED Informatics, Pharmaceutical Sciences, Clinical Pharmacology, and Neuroscience and Rare Diseases Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland
- 2Department of Neurology, McGill University, Montreal General Hospital, Montreal, Quebec, Canada
- 3Paracelsus-Elena-Klinik, Kassel, Germany
- 4Department of Neurology, University Medical Center Göttingen, Göttingen, Germany
- 5Idorisa Pharmaceuticals Ltd, Allschwil, Switzerland
- 6Prothena Biosciences Inc, South San Francisco, CA, USA
- ↵†Corresponding Author:
Florian Lipsmeier, Roche Pharma Research and Early Development, pRED Informatics, Roche Innovation Center, Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland, Telephone: +41 61 687 79 09, Email: florian.lipsmeier{at}roche.com
↵* equal contribution
Posted October 10, 2021.
Remote monitoring of progression in early Parkinson’s disease: reliability and validity of the Roche PD Mobile Application v2
